Trademarkia Logo

Canada

C$
IMPLAVAX
REGISTERED

on 8 Feb 2023

Last Applicant/ Owned by

ENESI PHARMA LIMITED

120 A&B Olympic Avenue,Milton ParkAbingdon, Oxfordshire OX14 4SA

GB

Serial Number

2057800 filed on 3rd Sept 2020

Registration Number

TMA1164582 registered on 8th Feb 2023

Registration expiry Date

3rd Sept 2030

Correspondent Address

OSLER, HOSKIN & HARCOURT LLP

SUITE 6200, P.O. BOX 501 FIRST CANADIAN PLACETORONTO

ONTARIO

CA

M5X1B8

IMPLAVAX

Trademark usage description

medical and veterinary research and development services; medical and veterinary device development services; pharmaceutical development services; pha Read More

Classification Information


Class [042]
Medical and veterinary research and development services; medical and veterinary device development services; pharmaceutical development services; pharmaceutical delivery system development services; preparation and formulation of pharmaceuticals; research into vaccines; medical and veterinary device and product testing services; Provision of information in the fields of medical, pharmaceutical, vaccine and veterinary research and product development; consultancy in the fields of medical, pharmaceutical, vaccine and veterinary research and product development and product testing.


Classification kind code

11

Mark Details


Serial Number

2057800

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 22
on 1st Feb 2022
Search Recorded
Submitted for opposition 20
on 1st Feb 2022
Examiner's First Report
Submitted for opposition 223
on 1st Feb 2022
Total Provisional Refusal
Submitted for opposition 256
on 16th Aug 2021
Notification of Possible Opposition Sent
Submitted for opposition 135
on 9th Dec 2020
Amendment to Application
Submitted for opposition 257
on 15th Oct 2020
Designation Notification - Madrid Protocol
Submitted for opposition 31
on 15th Oct 2020
Formalized
Submitted for opposition 1
on 15th Oct 2020
Created
Submitted for opposition 228
on 3rd Sept 2020
International Registration
Submitted for opposition 30
on 3rd Sept 2020
Filed